• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精-胚胎移植中促性腺激素释放激素拮抗剂起始的最佳时机:一项针对高龄产妇的回顾性队列研究。

Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women.

作者信息

Han Qiao-Song, Zhou Yue, Xu Ying, Ai Kai-Liang, Song Jing-Yan, Sun Zhen-Gao

机构信息

The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

The College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

出版信息

Front Endocrinol (Lausanne). 2024 Feb 5;15:1340230. doi: 10.3389/fendo.2024.1340230. eCollection 2024.

DOI:10.3389/fendo.2024.1340230
PMID:38375197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10875460/
Abstract

BACKGROUND

Several studies have compared the effects of fixed and flexible gonadotropin releasing hormone antagonist (GnRH-ant) protocols during fertilization and embryo transfer (IVF-ET). However, which GnRH-ant initiation strategy is better remains controversial. Moreover, no studies have assessed the optimal timing of GnRH-ant initiation in women of advanced maternal age (AMA).

METHODS

In this retrospective cohort study, a total of 472 infertile women aged ≥ 35 years old undergoing their first IVF cycle from August 2015 to September 2021 at a tertiary academic medical center were recruited, of whom 136 followed fixed GnRH-ant protocol and 336 followed flexible GnRH-ant protocol. The primary outcomes measured were the cumulative live birth rate (CLBR) per IVF cycle and the time to live birth (TTLB) from the date of oocyte retrieval. Cox proportional models were used to calculate the hazard ratio (HR) and 95% confidence interval (CI) of CLBR regarding GnRH-ant timing.

RESULTS

No significant difference in CLBR was found between the fixed and flexible GnRH-ant groups (27.9% vs 20.5%, p=0.105). The TTLB was also comparable between groups (10.56 vs 10.30 months, p=0.782). The Kaplan-Meier analysis for CLBR also showed comparable results between groups (P=0.351, HR=0.83; 95%CI: 0.56-1.23). After establishing a multiple Cox proportional hazard model, the fixed GnRH-ant group still had comparable CLBR with the flexible GnRH-ant group (HR=0.85; 95%CI: 0.53-1.38; P=0.518). Subgroup and sensitivity analyses also demonstrated similar results.

CONCLUSION

GnRH-ant protocols can be tailored to the needs of AMA women, and timing of GnRH-ant initiation can be adjusted flexibly.

摘要

背景

多项研究比较了固定和灵活促性腺激素释放激素拮抗剂(GnRH-ant)方案在体外受精-胚胎移植(IVF-ET)过程中的效果。然而,哪种GnRH-ant启动策略更好仍存在争议。此外,尚无研究评估高龄产妇(AMA)中GnRH-ant启动的最佳时机。

方法

在这项回顾性队列研究中,招募了2015年8月至2021年9月在一家三级学术医疗中心进行首次IVF周期的472名年龄≥35岁的不孕妇女,其中136名遵循固定GnRH-ant方案,336名遵循灵活GnRH-ant方案。测量的主要结局是每个IVF周期的累积活产率(CLBR)以及从取卵日期到活产的时间(TTLB)。使用Cox比例模型计算关于GnRH-ant时机的CLBR的风险比(HR)和95%置信区间(CI)。

结果

固定和灵活GnRH-ant组之间的CLBR无显著差异(27.9%对20.5%,p = 0.105)。两组之间的TTLB也相当(10.56对10.30个月,p = 0.782)。CLBR的Kaplan-Meier分析也显示两组结果相当(P = 0.351,HR = 0.83;95%CI:0.56 - 1.23)。建立多因素Cox比例风险模型后,固定GnRH-ant组的CLBR仍与灵活GnRH-ant组相当(HR = 0.85;95%CI:0.53 - 1.38;P = 0.518)。亚组和敏感性分析也显示了相似的结果。

结论

GnRH-ant方案可根据AMA女性的需求进行调整,GnRH-ant启动的时机可灵活调整。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1657/10875460/83103206707f/fendo-15-1340230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1657/10875460/d776d08c5f0c/fendo-15-1340230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1657/10875460/83103206707f/fendo-15-1340230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1657/10875460/d776d08c5f0c/fendo-15-1340230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1657/10875460/83103206707f/fendo-15-1340230-g002.jpg

相似文献

1
Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women.体外受精-胚胎移植中促性腺激素释放激素拮抗剂起始的最佳时机:一项针对高龄产妇的回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Feb 5;15:1340230. doi: 10.3389/fendo.2024.1340230. eCollection 2024.
2
Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.1050名女性在一个辅助生殖技术周期(包括所有后续冻融周期)后的累积活产率:一项比较促性腺激素释放激素拮抗剂和促性腺激素释放激素激动剂方案的随机对照试验的次要结果。
Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358.
3
Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.促性腺激素释放激素拮抗剂方案与孕激素预处理卵巢刺激方案对体外受精周期后累积活产率的比较:一项倾向评分匹配研究。
Fertil Steril. 2022 Oct;118(4):701-712. doi: 10.1016/j.fertnstert.2022.06.012. Epub 2022 Aug 6.
4
Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.在中国,一项 ART 周期中所有胚胎移植时,促性腺激素释放激素激动剂长方案与拮抗剂方案的累积活产率:来自中国的 18853 名女性的真实数据。
Reprod Biol Endocrinol. 2021 Aug 12;19(1):124. doi: 10.1186/s12958-021-00814-0.
5
Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders.促性腺激素释放激素拮抗剂方案与多次微刺激对卵巢低反应患者的累积活产率和成本效益分析。
Front Endocrinol (Lausanne). 2021 Jan 14;11:605939. doi: 10.3389/fendo.2020.605939. eCollection 2020.
6
Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.孕激素预处理卵巢刺激与灵活 GnRH 拮抗剂方案在低预后患者中累积活产率的比较。
Front Endocrinol (Lausanne). 2021 Sep 13;12:705264. doi: 10.3389/fendo.2021.705264. eCollection 2021.
7
The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.促性腺激素释放激素激动剂扳机方案可提高新鲜胚胎移植周期的活产率,但不能提高正常反应者的累积活产率:一项随机对照试验及分子机制研究。
Hum Reprod. 2020 Jun 1;35(6):1306-1318. doi: 10.1093/humrep/deaa086.
8
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
9
[Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].[GnRH拮抗剂固定方案与GnRH激动剂长方案在首次体外受精-胚胎移植周期中卵巢储备功能正常的不孕患者中的比较]
Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):245-9.
10
Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial.在卵巢储备正常的不孕妇女中,使用孕激素预刺激卵巢刺激与促性腺激素释放激素拮抗剂方案进行体外受精周期的累积活产率:一项开放标签、随机对照试验。
Hum Fertil (Camb). 2024 Dec;27(1):2316005. doi: 10.1080/14647273.2024.2316005. Epub 2024 Feb 15.

引用本文的文献

1
Comparison of pregnancy outcomes and safety between cetrorelix and ganirelix in IVF/ICSI antagonist protocols: a retrospective cohort study.在体外受精/卵胞浆内单精子注射拮抗剂方案中,西曲瑞克和加尼瑞克对妊娠结局及安全性的比较:一项回顾性队列研究
Front Reprod Health. 2025 Apr 14;7:1492441. doi: 10.3389/frph.2025.1492441. eCollection 2025.
2
Does the Timing of Antagonist Treatment Influence Cycle Outcomes in Unexpected Low Responders of POSEIDON Class 1 and 2?拮抗剂治疗时机是否会影响波塞冬1类和2类意外低反应者的周期结局?
J Clin Med. 2025 Mar 12;14(6):1901. doi: 10.3390/jcm14061901.
3
Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT.

本文引用的文献

1
What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.ART 治疗中卵巢刺激时最佳 GnRH 拮抗剂方案是什么?系统评价和网络荟萃分析。
Hum Reprod Update. 2023 May 2;29(3):307-326. doi: 10.1093/humupd/dmac040.
2
Preventing Growth Stagnation and Premature LH Surge Are the Keys to Obtaining a Viable Embryo in Monofollicular IVF Cycles: A Retrospective Cohort Study.预防生长停滞和过早促黄体生成素峰是单卵泡体外受精周期中获得可存活胚胎的关键:一项回顾性队列研究。
J Clin Med. 2022 Dec 1;11(23):7140. doi: 10.3390/jcm11237140.
3
A Premature Rise of Luteinizing Hormone Is Associated With a Reduced Cumulative Live Birth Rate in Patients ≥37 Years Old Undergoing GnRH Antagonist Fertilization Cycles.
多囊卵巢综合征女性体外受精中固定剂量与灵活剂量促性腺激素释放激素拮抗剂方案的比较:一项随机对照试验
Int J Reprod Biomed. 2024 Oct 14;22(8):617-626. doi: 10.18502/ijrm.v22i8.17230. eCollection 2024 Aug.
促黄体生成素提前升高与 GnRH 拮抗剂促排卵周期中≥37 岁患者累积活产率降低相关。
Front Endocrinol (Lausanne). 2021 Dec 2;12:722655. doi: 10.3389/fendo.2021.722655. eCollection 2021.
4
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.重组人促黄体生成激素在高龄妇女辅助生殖技术卵巢刺激中的联合治疗:随机对照试验的系统评价和荟萃分析。
Reprod Biol Endocrinol. 2021 Jun 21;19(1):91. doi: 10.1186/s12958-021-00759-4.
5
Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.促性腺激素释放激素拮抗剂方案控制性卵巢刺激中血清 LH 水平低会降低新鲜胚胎移植后的活产率,但在全冷冻周期中无影响。
Front Endocrinol (Lausanne). 2021 Apr 23;12:640047. doi: 10.3389/fendo.2021.640047. eCollection 2021.
6
Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial.非 PCOS 预测卵巢高反应患者拮抗剂方案中固定与灵活方案的比较:一项随机对照试验。
BMC Pregnancy Childbirth. 2021 May 2;21(1):348. doi: 10.1186/s12884-021-03833-2.
7
Assisted conception in women of advanced maternal age.高龄产妇的辅助受孕。
Best Pract Res Clin Obstet Gynaecol. 2021 Jan;70:10-20. doi: 10.1016/j.bpobgyn.2020.06.012. Epub 2020 Aug 7.
8
Time to pregnancy: as important for patients as underestimated by doctors.受孕时间:对患者至关重要却被医生低估。
Fertil Steril. 2020 Mar;113(3):522-523. doi: 10.1016/j.fertnstert.2019.12.025. Epub 2020 Feb 25.
9
Frozen embryo transfer at the cleavage stage can be performed within the first menstrual cycle following the freeze-all strategy without adversely affecting the live birth rate: A STROBE-compliant retrospective study.卵裂期冻融胚胎移植可在采用全胚冷冻策略后的第一个月经周期内进行,且不会对活产率产生不利影响:一项符合STROBE标准的回顾性研究。
Medicine (Baltimore). 2019 Sep;98(38):e17329. doi: 10.1097/MD.0000000000017329.
10
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.体外受精中的高龄产妇:仍是一项挑战?其治疗的现状与未来
Front Endocrinol (Lausanne). 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094. eCollection 2019.